Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Inventory

Raw materials, work in progress, and finished goods held for sale.

Medtronic plcNYSE: MDT

Inventory · Q1 FY2027 · quarter ended Jul 2026

Inventory remains negative

Q1 FY2027 inventory was -$240M, compared with -$373M a year earlier. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Inventory amounted to 0.3% of total assets at the end of Q1 FY2027, down 0.2 pp from a year earlier.
  • Inventory increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +35.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJul 2026
-$240M-104.0% QoQ
Last fiscal yearApr 2026
$5.95B+8.7% YoY
Year agoJul 2025
-$373M+35.7% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+35.7%——
1 year+8.7%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2026
5.95B USD
Year-over-year change
+8.7%
4-year CAGR
+6.6%

Inventory vs competitors

How MDT compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +35.7% is the highest of 9, against a peer median of +1.5%.
  • Inventory amounts to 0.3% of total assets for MDT, versus a peer median of 7.7%.
MDT Competitors
Inventory for MDT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYKStryker CorporationJun 2026$5.52B USD+4.4%+9.9%11.5%
BSXBoston Scientific CorporationJun 2026$3.24B USD+13.1%+16.4%7.2%
PHGKoninklijke Philips N.V.Jun 2026€3.22B EUR-0.5%-10.8%12.0%
EWEdwards Lifesciences CorporationJun 2026$1.13B USD-0.9%+8.8%8.2%
PENPenumbra, Inc.Jun 2026$442.65M USD+3.5%+8.9%22.4%
LIVNLivaNova PLCSep 2026$177.9M USD+6.2%+8.4%6.6%
AVRAnteris Technologies Global Corp.Mar 2026$122K USD-66.5%+27.4%0.0%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$0 USD-100.0%+2.1%0.0%
MDTMedtronic plcJul 2026-$240M USD+35.7%+4.0%0.3%
Peer median (excluding MDT) —+1.5%+8.8%7.7%

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Cash & Equivalents3.71B1.54B1.28B2.22B1.95B
Short-term Investments6.86B6.42B6.72B6.75B7.27B
Net Receivables5.55B6B6.13B6.52B6.64B
Inventory4.62B5.29B5.22B5.48B5.95B
Other Current Assets2.32B2.43B2.59B2.86B2.97B
Total Current Assets23.06B21.68B21.94B23.81B24.79B
Property, Plant & Equipment (Net)5.41B5.57B6.13B6.84B7.42B
Goodwill40.5B41.43B40.99B41.74B42.59B
Intangible Assets15.59B14.84B13.23B11.67B10.15B
Long-term Investments00000
Tax Assets00000
Other Non-current Assets6.41B7.44B7.7B7.62B8.09B
Total Non-current Assets67.92B69.27B68.05B67.87B68.24B
Total Assets90.98B90.95B89.98B91.68B93.03B
Account Payables2.28B2.66B2.41B2.45B2.64B
Short-term Debt3.74B13M1.09B2.87B1.78B
Tax Payables704M840M1.33B0914M
Deferred Revenue00000
Other Current Liabilities2.12B1.95B2.38B2.52B2.68B
Total Current Liabilities12.39B9.05B10.79B12.88B11.66B
Long-term Debt20.32B24.29B23.88B25.59B26.12B
Deferred Tax Liabilities884M708M515M403M362M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities4.61B5.18B4.33B4.5B4.76B
Total Non-current Liabilities25.87B30.23B28.77B30.55B31.3B
Total Liabilities38.26B39.28B39.56B43.42B42.96B
Common Stock00000
Retained Earnings30.25B30.39B30.4B31.48B32.64B
Accumulated OCI(2.27B)(3.5B)(3.32B)(4.28B)(4.1B)
Other Stockholders Equity000(1M)0
Minority Interest171M182M206M232M609M
Total Equity52.72B51.67B50.42B48.26B50.07B
Total Debt24.11B24.36B25.02B28.52B27.96B
Net Debt20.4B22.82B23.74B26.3B26.01B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.